Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Chemocentryx Inc (CCXI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2019	09-2019	06-2019	03-2019	12-2018
Assets
Current Assets
Cash & Cash Equivalents	39,179	35,922	38,745	79,333	28,088
Marketable Securities	133,607	135,011	160,612	142,777	148,896
Receivables	176	N/A	N/A	167	2,058
TOTAL	$174,362	$172,519	$202,003	$226,676	$181,384

Non-Current Assets
PPE Net	2,154	1,588	1,496	1,441	1,536
Investments And Advances	29,454	34,867	23,766	11,968	0
Other Non-Current Assets	3,113	3,347	2,546	1,272	390
TOTAL	$34,721	$39,802	$27,808	$14,681	$1,926

Total Assets	$209,083	$212,321	$229,811	$241,357	$183,310

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	1,532	937	974	1,293	966
Accrued Expenses	19,806	17,597	14,573	12,865	12,969
TOTAL	$59,080	$55,353	$56,662	$66,108	$64,396

Non-Current Liabilities
Long Term Debt	19,786	19,762	19,738	19,714	19,689
Deferred Revenues	37,742	36,819	41,115	51,950	50,461
Other Non-Current Liabilities	1,122	1,455	1,777	445	387
TOTAL	$84,003	$95,106	$101,689	$94,610	$104,176

Total Liabilities	$143,083	$150,459	$158,351	$160,718	$168,572

Shareholders' Equity
Shares Outstanding, K	61,645	58,269	58,250	58,048	52,569
Common Shares	60	58	58	58	51
Retained earnings	-429,986	-414,458	-401,596	-386,446	-374,497
Other shareholders' equity	302	393	337	-20	-214
TOTAL	$66,000	$61,862	$71,460	$80,639	$14,738

Total Liabilities And Equity	$209,083	$212,321	$229,811	$241,357	$183,310